Friday, 27 March 2026
  
Login

Australia's most trusted
source of pharma news

Friday, 27 March 2026
Ascott 2
Ascott 2
PBAC fails the pub test on women

The PBAC has copped a spray over its failure to recommend a treatment for women, with the pharma company's leader declaring the Committee's decision had failed the pub test on gender equity.

Novartis presses for cancer reform
Report launched at Parliament House has exposed the hidden cost of early breast cancer and outlines a clear action plan
TODAY
Now sports are looking at GLP-1s
Anti-doping bodies are monitoring the use of certain weight loss drugs for signs of abuse by athletes with a possible ban on the cards
TODAY
Who's on the PBAC's July Agenda?
The PBAC has dropped a packed agenda ahead of its July meeting, featuring 50 submissions, including 31 new listings
26 March
Company unveils role 'streamlining'
Details are light but this company is restructuring its corporate functions and simplifying its processes using advanced technologies
26 March
Why it's quitting time for pharma
Industry recruitment specialists have warned to brace for resignations as bonuses land in bank accounts
25 March
Which pharmas are Most Ethical?
Five pharmas have been honoured amongst the World's Most Ethical Companies, and Ethisphere says it pays off in the share price
25 March
Latest Jobs
Pharma targets US$320B market
Although the financial details remain undisclosed, this company has added up to five assets, bringing its pipeline to a total of 32
26 March
Companies chase listing changes
A dozen pharmas are seeking to change up existing PBS listings - one wants a revised risk sharing arrangement another, a better price
26 March
More head-turning data arrives
This ASX-listed company has reported a 100 per cent overall response rate in preliminary data... and it's not the first time
26 March
PBS giant hangs on tight
A mega-blockbuster is tumbling off a patent cliff in Europe and the US, but the Australian market is a much-needed bright spot
25 March
New Horizon for Aussie research
Joining Horizon Europe will benefit local research and development, and align our HTA processes more closely with Europe's
25 March
Roche takes lead in AI race
Swiss giant does a deal for the largest networked computing power in pharma to support otherwise impossible discoveries
25 March
Most expensive drug out of stock
The most expensive drug approved for use in Australia is suffering supply issues, leading to a temporary global stockout
24 March
Where Drs say pharma falls short
New survey has found a monster value gap between industry's delivery of information and 'practical usefulness'
24 March
Call out for Aussie innovators
Gilead is funding fellowships for local, innovative, practice-focused projects researching ways to improve the patient experience
24 March
'Weeks away' from supply choke
Logistics expert warns supply of some of Australia's highest-volume medicines could be hit if Strait of Hormuz stand-off escalates
24 March
$90B time bomb exposed
Australia could face a $90 billion-a-year crisis within a decade without coordinated policy action, including access to new therapies
24 March
Ex-J&J staffer sued for secrets 'theft'
Pharma giant claims ex-employee committed industrial espionage after bad performance review, downloading 7000 confidential files
23 March
Fresh fallout from PBAC rejections
Aside from the clear impact on patients, PBAC rejections are taking a human toll on staffers within pharma companies
23 March
Who's back in Aust for a new role?
After six years in Canada - and 25 years at Roche - this high-flyer has been snapped up by a rival company for a newly-created role
23 March
PiF Advertise
PiF Advertise
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.